Skip to main content
. 2016 Apr 16;5(2):89–112. doi: 10.1007/s40121-016-0107-0

Table 2.

Summary of meningococcal vaccination recommendations

graphic file with name 40121_2016_107_Tab2a_HTML.jpg

graphic file with name 40121_2016_107_Tab2b_HTML.jpg

graphic file with name 40121_2016_107_Tab2c_HTML.jpg

graphic file with name 40121_2016_107_Tab2d_HTML.jpg

Adapted from Specific National Guidelines [65–70]

Hib/MenCCV H. influenzae b/monovalent meningococcal C conjugate vaccine, MenBV meningococcal B vaccine, MenCCV monovalent meningococcal C conjugate vaccine, 4vMenCV quadrivalent meningococcal conjugate vaccine, 4vMenPV quadrivalent meningococcal polysaccharide vaccine

a2-dose initial vaccine series recommended

bIncluded deficiencies: C3, C5–9, properdin, factor D, and factor H. In addition, the use of medications that inhibit any of these components, such as eculizumab